Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-02

Clinical Trial Update: Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength

View source ↗

Summary

A completed clinical trial investigating how glycemic control influences bone strength and skeletal fragility in individuals with Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Columbia University | Conditions: Type1diabetes | Status: COMPLETED